1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole has been researched along with Kahler Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dong, X; Gao, H; Pan, J; Ren, Y; Tian, Y; Wang, L; Wang, W; Zhao, W | 1 |
1 other study(ies) available for 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole and Kahler Disease
Article | Year |
---|---|
Orai1 and Stim1 Mediate the Majority of Store-Operated Calcium Entry in Multiple Myeloma and Have Strong Implications for Adverse Prognosis.
Topics: Adult; Aged; Apoptosis; Bone Marrow; Calcium; Calcium Channel Blockers; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Female; Humans; Imidazoles; Male; Middle Aged; Multiple Myeloma; Neoplasm Proteins; ORAI1 Protein; Prognosis; RNA Interference; RNA, Small Interfering; Stromal Interaction Molecule 1 | 2018 |